While Moderna News Today

Moderna still has big ambitions -- beyond the coronavirus vaccine -- that could pay off in a few years.

/PRNewswire/ -- Promosome LLC, represented by Susman Godfrey, has filed major patent infringement actions against pharmaceutical behemoths Moderna, Pfizer, and...

A cancer vaccine deal with pharma heavyweight Merck is lighting a fire underneath the biotech's shares today.

Wall Street thinks the bear market has pushed this top biotech stock down too far.

The recently approved Pune-based Gennova Biopharmaceuticals' two-dose mRNA Covid-19 vaccine, expected to be soon available in the country, is likely to see low penetration in the Indian market, according to a report on Monday.The jab ...

Another COVID-19 booster dose could be recommended for older Coloradans as soon as Tuesday, a Colorado health official said Monday afternoon, though federal funding worries may disrupt further distribution plans.

BioPharma

According to the Centers for Disease Control (CDC), serious adverse events after COVID-19 vaccination are rare but may occur.

The Food and Drug Administration told the company that its review could last until January.

The Food and Drug Administration told the company that its review could last until January.